GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Long-Term Debt

Microba Life Sciences (ASX:MAP) Long-Term Debt : A$0.51 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Long-Term Debt?

Microba Life Sciences's Long-Term Debt for the quarter that ended in Dec. 2023 was A$0.51 Mil.

Microba Life Sciences's quarterly Long-Term Debt declined from Dec. 2022 (A$0.47 Mil) to Jun. 2023 (A$0.00 Mil) but then increased from Jun. 2023 (A$0.00 Mil) to Dec. 2023 (A$0.51 Mil).

Microba Life Sciences Long-Term Debt Historical Data

The historical data trend for Microba Life Sciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Long-Term Debt Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23
Long-Term Debt
- -

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Long-Term Debt - - 0.47 - 0.51

Microba Life Sciences  (ASX:MAP) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Microba Life Sciences Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Microba Life Sciences (ASX:MAP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Long-Term Debt
Comparable Companies
ASX:GSS ASX:IIQ ASX:RHY ASX:LDX ASX:CTE ASX:GTG ASX:BDX ASX:IBX TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX
Traded in Other Exchanges
N/A
Address
324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Website
https://www.microba.com
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines